tradingkey.logo

Universe Pharmaceuticals Inc

UPC
3.980USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.24MMarktkapitalisierung
0.00KGV TTM

Universe Pharmaceuticals Inc

3.980
0.0000.00%

mehr Informationen über Universe Pharmaceuticals Inc Unternehmen

Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.

Universe Pharmaceuticals Inc Informationen

BörsenkürzelUPC
Name des UnternehmensUniverse Pharmaceuticals Inc
IPO-datumMar 23, 2021
CEOLai (Gang)
Anzahl der mitarbeiter225
WertpapierartOrdinary Share
GeschäftsjahresendeMar 23
Addresse265 Jingjiu Avenue
StadtJI'AN
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl343100
Telefon867968403309
Websitehttp://www.universe-pharmacy.com/
BörsenkürzelUPC
IPO-datumMar 23, 2021
CEOLai (Gang)

Führungskräfte von Universe Pharmaceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%
Nach RegionUSD
Name
Umsatz
Anteil
China (Mainland)
23.02M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%

Aktionärsstatistik

Aktualisiert: Sun, Jan 18
Aktualisiert: Sun, Jan 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Sabby Management, LLC
4.99%
Sununion Holding Group Ltd
0.62%
Osaic Holdings, Inc.
0.35%
UBS Financial Services, Inc.
0.17%
Andere
93.87%
Aktionäre
Aktionäre
Anteil
Sabby Management, LLC
4.99%
Sununion Holding Group Ltd
0.62%
Osaic Holdings, Inc.
0.35%
UBS Financial Services, Inc.
0.17%
Andere
93.87%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
4.99%
Corporation
0.62%
Investment Advisor
0.52%
Andere
93.87%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
15
31.06K
5.51%
+24.54K
2025Q3
14
--
0.00%
-15.11K
2025Q2
15
3.73K
0.66%
-14.56K
2025Q1
15
3.73K
8.84%
-14.56K
2024Q4
15
702.49K
4.61%
+518.42K
2024Q3
12
183.86K
3.78%
+44.54K
2024Q2
8
139.13K
0.94%
-3.04K
2024Q1
8
138.86K
57.13%
-3.66K
2023Q4
9
139.20K
57.27%
-3.80K
2023Q3
13
139.26K
57.29%
-143.15K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Sabby Management, LLC
28.11K
4.99%
+28.11K
--
Dec 31, 2025
Sununion Holding Group Ltd
3.47K
0.62%
--
--
Apr 29, 2025
Osaic Holdings, Inc.
2.00K
0.35%
+2.00K
--
Sep 30, 2025
UBS Financial Services, Inc.
1.00
0%
+1.00
--
Sep 30, 2025
StoneX Group Inc.
--
0%
-25.00
-100.00%
Dec 31, 2024
Anson Funds Management LP.
--
0%
-5.76K
-100.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
--
0%
-2.00
-100.00%
Mar 31, 2025
MML Investors Services, LLC
--
0%
-390.00
-100.00%
Dec 31, 2024
Quadrature Capital LLP
--
0%
-41.00
-100.00%
Dec 31, 2024
Virtu Americas LLC
--
0%
-28.00
-100.00%
Dec 31, 2024
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Nov 14, 2024
Merger
15→1
Nov 14, 2024
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Mar 20, 2025
Merger
40→1
Nov 14, 2024
Merger
15→1
Nov 14, 2024
Merger
15→1
Nov 14, 2024
Merger
15→1
Nov 14, 2024
Merger
15→1
Jul 27, 2023
Merger
6→1
Jul 27, 2023
Merger
6→1
Mehr Anzeigen
KeyAI